Overview

Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants

Status:
Unknown status
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The goal of this research program is to understand the natural history of asymptomatic bacteriuria in the renal transplant patients, to determine if screening for asymptomatic bacteriuria and identification of key host characteristics and virulence factors present on uropathogenic bacteria identifies a sub-population of patients with asymptomatic bacteriuria that are at risk to develop symptomatic urinary tract infection. Ultimately, the knowledge obtained from this study will prevent inappropriate antibiotic use and may identify whether certain bacterial isolates predispose to renal allograft injury. We will test the hypothesis that (i) asymptomatic bacteriuria is common in the renal allograft recipient and (ii) that symptomatic urinary tract infection and renal allograft dysfunction do not occur unless key host susceptibility factors and uropathogenic bacterial virulence factors are present.
Details
Lead Sponsor:
Rice, James C., M.D.
Collaborator:
University of Alabama at Birmingham
Treatments:
Ampicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefazolin
Ciprofloxacin
Gentamicins
Levofloxacin
Nitrofurantoin
Ofloxacin
Sulbactam
Sulfamethoxazole
Tobramycin
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination